Genomic epidemiology of global carbapenemase-producing Escherichia coli, 2015–2017

Show simple item record

dc.contributor.author Peirano, Gisele
dc.contributor.author Chen, Liang
dc.contributor.author Nobrega, Diego
dc.contributor.author Finn, Thomas J.
dc.date.accessioned 2023-06-08T05:12:28Z
dc.date.available 2023-06-08T05:12:28Z
dc.date.issued 2022-05
dc.description.abstract We describe the global molecular epidemiology of 229 carbapenemase-producing Escherichia coli in 36 countries during 2015–2017. Common carbapenemases were oxacillinase (OXA) 181 (23%), New Delhi metallo-β-lactamase (NDM) 5 (20%), OXA-48 (17%), Klebsiella pneumoniae carbapenemase 2 (15%), and NDM-1 (10%). We identified 5 dominant sequence types (STs); 4 were global (ST410, ST131, ST167, and ST405), and 1 (ST1284) was limited to Turkey. OXA-181 was frequent in Jordan (because of the ST410-B4/H24RxC subclade) and Turkey (because of ST1284). We found nearly identical IncX3-blaOXA-181 plasmids among 11 STs from 12 countries. NDM-5 was frequent in Egypt, Thailand (linked with ST410-B4/H24RxC and ST167-B subclades), and Vietnam (because of ST448). OXA-48 was common in Turkey (linked with ST11260). Global K. pneumoniae carbapenemases were linked with ST131 C1/H30 subclade and NDM-1 with various STs. The global carbapenemase E. coli population is dominated by diverse STs with different characteristics and varied geographic distributions, requiring ongoing genomic surveillance. en_US
dc.description.department Medical Microbiology en_US
dc.description.librarian am2023 en_US
dc.description.sponsorship The Joint Programming Initiative on Antimicrobial Resistance–Canadian Institute Health Research program and the US National Institutes of Health. en_US
dc.description.uri http://wwwnc.cdc.gov/eid en_US
dc.identifier.citation Peirano, G., Chen, L., Nobrega, D. et al. 2022, 'Genomic epidemiology of global carbapenemase-producing escherichia coli, 2015–2017', Emerging Infectious Diseases, vol. 28, no. 5, pp. 924-931, doi : 10.3201/eid2805.212535. . en_US
dc.identifier.issn 1080-6040 (print)
dc.identifier.issn 1080-6059 (online)
dc.identifier.other 10.3201/eid2805.212535
dc.identifier.uri http://hdl.handle.net/2263/91048
dc.language.iso en en_US
dc.publisher Centers for Disease Control and Prevention en_US
dc.rights © 2022, Centers for Disease Control and Prevention (CDC). All rights reserved. en_US
dc.subject Surveillance en_US
dc.subject Carbapenemases en_US
dc.subject Molecular epidemiology en_US
dc.subject Escherichia coli en_US
dc.subject Bacteria en_US
dc.subject Whole-genome sequencing (WGS) en_US
dc.subject Antimicrobial resistance (AMR) en_US
dc.title Genomic epidemiology of global carbapenemase-producing Escherichia coli, 2015–2017 en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record